Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page
- Check7 days agoChange DetectedThe page revision history was updated: a new Revision: v3.5.4 was added and the previous Revision: v3.5.3 was removed. This update records a small metadata/version bump to the page, not altering study content or functionality.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer revision number is updated from v3.5.2 to v3.5.3, reflecting a website build/version change rather than any modification to the study details.SummaryDifference0.0%

- Check36 days agoChange DetectedTemuco, Chile location updated from 'Temuco, Región de la Araucanía, Chile, 4780000' to 'Temuco, Araucania, Chile, 4780000'. Revision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check50 days agoChange DetectedLocation entry updated from Padua, Italy, 35128 to Padova, Italy, 35128 in the study's locations list.SummaryDifference0.0%

- Check64 days agoChange DetectedNapoli, Italy, 80131 was renamed to Naples, Italy, 80131, and the page revision updated to v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.